In renal proximal tubule epithelial cells, a membrane-associated phospholipase A 2 (PLA 2 ) is a major signaling pathway linked to angiotensin II (Ang II) type 2 receptor (AT 2 ). The current studies were designed to test the hypothesis that membrane-associated PLA 2 -induced release of arachidonic acid (AA) and͞or its metabolites may serve as an upstream
Angiotensin II (Ang II), a potent vasoconstrictor and modulator of ion transport, also is known to induce mitogenesis associated with mitogen-activated protein kinase (MAPK) in a variety of cells (1) (2) (3) (4) (5) (6) . Earlier studies described a protein kinase C (PKC)-dependent mechanism of Ang II-induced activation of MAPK in adrenocortical cells and cardiac fibroblasts (1, 5) , which also involved phospholipase C (PLC)-mediated production of inositol trisphosphates and diacyl glycerol (1, 5) . More recently, an alternative p21 ras -dependent mechanism was described in cardiac myocytes, which involved phosphorylation of adaptor protein Shc by intracellular tyrosine kinases and association of Shc with Grb2͞Sos complex, followed by activation of p21 ras (6) . In renal proximal tubular epithelial (RTE) cells, the Ang II signaling is not linked to PLC (7, 8) . Our laboratory (7) and others (9, 10 ) have demonstrated that a major second messenger of Ang II in proximal tubular epithelium is phospholipase A 2 (PLA 2 ) and its product, arachidonic acid (AA). Therefore, we reasoned that AA and͞or its metabolites could mediate the effect of Ang II on MAPK. This hypothesis also was based on observations demonstrating that AA and its metabolites elicited mitogenic activity in other cells (11) (12) (13) .
In the present study we propose a PLA 2 -dependent mechanism of activation of MAPK in proximal tubule epithelium, mediated by AA and͞or its cytochrome P450-dependent metabolites, which may provide a linkage between Ang II receptor and intracellular tyrosine kinases in the p21 ras -dependent pathway of activation of MAPK cascade.
EXPERIMENTAL PROCEDURES
Materials. Sar 1 -Ang II, a stable analog of Ang II, used in experiments, was obtained from Peninsula Laboratories. AA was obtained from Biomol (Plymouth Meeting, PA). 5,6-Epoxyeicosatrienoic acid (EET) and 14,15-EET were synthesized as previously described (14) . The inhibitors of AA metabolism were from Sigma. [ Cell Culture. The rabbit RTE cells were isolated from male New Zealand White rabbits (Hazelton Research Products, Denver, PA) as previously described (15) . The standard growth medium for RTE cells was a 50:50 mixture of DMEM and Ham's F-12 media supplemented with 15 mM Hepes (pH 7.4), 0.35 mg͞ml of L-glutamine, 0.6 mg͞ml of sodium bicarbonate, 100 units͞ml of penicillin, 100 mg͞ml of streptomycin, 5 g͞ml of bovine insulin, 5 g͞ml of human transferrin, 0.5 M hydrocortisone, and 5% fetal bovine serum. The firstpassaged RTE cells were serum-starved for 48 hr before the experiment.
Phosphorylation and Activation of MAPK. After stimulation with different agonists, the cells were washed twice with ice-cold PBS, lysed in a buffer containing 25 mM Hepes (pH 7.5), 150 mM NaCl, 1.5 mM MgCl 2 , 1 mM EGTA, 10% Triton X-100, 1 mM phenylmethylsulfonyl fluoride, 1 M leupeptin, 10 g͞ml of pepstatin, 50 g͞ml of bestatin, 200 M Naorthovanadate, and 1 mM NaF. The lysed cells were scraped and centrifuged at 14,000 rpm for 20 min in the microcentrifuge. Phosphorylation of MAPK was determined by Western blot analysis of cell lysates with antibodies against ␣PMAPK, or as an electrophoretic mobility shift by immunoblotting with MAPK antibodies (␣MAPK 63480).
MAPK activity was measured as described previously (16) . Briefly, MAPK was immunoprecipitated from cell lysates with ERK1 antibodies followed by kinase assay with myelin basic protein (MBP) as a substrate. The phosphorylation of MBP was quantified by liquid scintillation spectrometry after separation by electrophoresis.
Measurement of AA Release. RTE cells, grown in 12-well plates, were labeled with [ 3 H]AA (1 Ci͞ml) for 4 hr and washed three times with 1 ml of DMEM͞F12 containing 0.1% BSA. After stimulation with agonists for 5 min, the medium was removed, and the radioactivity in the medium was quantified by liquid scintillation spectrometry.
RESULTS
Effect of Ang II and AA on MAPK Phosphorylation. Incubation of RTE cells with Ang II resulted in a dose-dependent phosphorylation of p42 and p44 isoforms of MAPK (Erk1 and Erk2, respectively) as determined by immunoblotting the cell lysates with ␣PMAPK, as well as by electrophoretic mobility shift of ERK1, detected by Western blotting with p42͞p44 MAPK antibodies (␣PMAPK, Fig. 1 ). Phosphorylation of MAPK was detectable at 10 nM Ang II and reached maximum at 1 M Ang II. This is consistent with the involvement of the relatively low affinity Ang II binding site on the apical surface of previously described rabbit proximal tubule epithelium by our laboratory (17) .
Previous studies have demonstrated that Ang II stimulates PLA 2 and rapid release of AA, using both intact RTE cells (18, 19) and renal brush border membrane vesicles (9) . To evaluate the role of PLA 2 in the mechanism of activation of MAPK, we first examined the influence of PLA 2 inhibitor, mepacrine, on Ang II-induced release of AA and phosphorylation of MAPK. Ang II stimulated more than a 2-fold increase in AA release within 5 min of incubation with RTE cells, and this effect was significantly decreased by 76 Ϯ 13% in the presence of mepacrine ( Fig. 2A) . Preincubation of RTE cells with mepacrine also diminished MAPK phosphorylation induced by Ang II (Fig. 2B ), suggesting the importance of PLA 2 in Ang II signaling. Selective inhibitors of cPLA 2 (AACOCF 3 ) and sPLA 2 (manoalide) did not alternate Ang II-induced MAPK phosphorylation (data not shown). Because AA can be produced in an alternative manner through PLC signaling pathways and diacylglycerol (DAG), we used the specific DAG lipase inhibitor RHC-80267 but found no effect on basal or Ang II-induced MAPK phosphorylation (data not shown).
Direct addition of AA resulted in dose-dependent phosphorylation of MAPK in RTE cells (Fig. 3A) . The effect of AA was detectable at 1.5 M and reached maximum at 15 M. Direct assessment of MAPK activity confirmed that phosphorylation of MAPK was associated with an increase in its activity (data not shown). The time course of MAPK phosphorylation demonstrated that the effect of AA on MAPK phosphorylation was more rapid (maximum at 3-5 min) than the effect of Ang II (maximum at 10-15 min), consistent with the hypothesis that AA mediates MAPK phosphorylation, induced by Ang II (Fig. 3 B and C) .
Activation of MAPK by Ang II and AA Is PKC Independent. To evaluate the role of PKC in the mechanism of MAPK activation, we examined the effect of the PKC inhibitor staurosporine on MAPK phosphorylation, induced by Ang II Proc. Natl. Acad. Sci. USA 95 (1998) and AA, as compared with the PKC activator phorbol 12-myristate 13-acetate (PMA). The choice of staurosporine was based on the fact that it is one of the most potent and less selective inhibitors of PKC, having the broadest range of activity toward different specific isoforms of PKC (19) . Thus, when the involvement of a specific isoform of PKC is not known, staurosporine can be a useful tool for defining the role of PKC in general.
As shown in Fig. 4 , PMA stimulated phosphorylation of MAPK in RTE cells to the same extent as Ang II and AA. Preincubation of cells with staurosporine resulted in a dosedependent inhibition of MAPK phosphorylation induced by PMA with a maximal effect at 200 nM (Fig. 4A) . In contrast, 200 nM of staurosporine did not inhibit AA-induced MAPK phosphorylation ( Fig. 4B) and had a negligible effect on Ang II-induced MAPK phosphorylation (Fig. 4C) . These data suggest that in RTE cells the mechanism of MAPK activation by Ang II and AA is PKC independent in contrast to earlier reports in other cell types (20, 21) . This supports our additional studies that document tyrosine phosphorylation of the adapter protein Shc, association with Grb2͞Sos, and activation of p21 ras (22) . Cytochrome P450 Products Mediate the Effect of Ang II and AA on MAPK Phosphorylation. To investigate whether MAPK phosphorylation is mediated by metabolites of AA, we first examined the effect of several specific inhibitors of AA metabolism on phosphorylation of MAPK. Previous studies have documented that in renal proximal tubular epithelium, AA is metabolized via cytochrome P450 system, rather than through the cyclooxygenase or lipoxygenase pathways of eicosanoid biosynthesis (7). In our experiments, the cyclooxygenase inhibitor indomethacin (100 M) had no effect on phosphorylation of MAPK induced by Ang II or AA (Fig. 5) . In contrast, the inhibitor of cytochrome P450 isozymes ketoconazole (100 M) completely abolished phosphorylation of MAPK induced by both Ang II and AA (Fig. 5) . Interestingly, the lipoxygenase inhibitor nordihydroguaiaretic acid (NDGA, 10 M) abolished MAPK phosphorylation induced by AA, but not by Ang II (Fig. 5 ). All three inhibitors had no effect on serum-induced MAPK phosphorylation (Fig. 5) . These results 
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Cell Biology: Dulin et al. Proc. Natl. Acad. Sci. USA 95 (1998) suggest that the cytochrome P450-dependent metabolites of AA may mediate the effect of Ang II on activation of MAPK.
To validate the role of cytochrome P450 in the mechanism of MAPK phosphorylation, we examined a direct effect of epoxy derivatives of AA, implicated in proximal tubular epithelial signaling linked to Ang II (7), on the activity of MAPK. As shown in Fig. 6 , addition of 5,6-EET and 14,15-EET significantly increased MAPK activity in RTE cells by 48% and 67%, respectively, as compared with control. The other AA metabolites [5-hydroxyeicosatetraenoic acid (HETE), 12-HETE, 15-HETE, 20-HETE, leukotrienes B 4 and C 4 ], some of which have been previously reported to be implicated in mitogenesis and MAPK activation (11-13, 20, 23) , had no effect on MAPK in RTE cells (data not shown).
DISCUSSION
Phosphorylation and activation of MAPK by Ang II has been previously demonstrated in adrenocortical (1), renal mesangial (2), vascular smooth muscle cells (3), and cardiac myocytes and fibroblasts (4, 5) . In these cells, the mechanism of MAPK activation by Ang II primarily involves signaling linked to inositol-specific PLC. Our present work documents a critical role of PLA 2 as an alternative mechanism of Ang II-induced activation of MAPK in RTE cells. Thus, inhibition of AA release by mepacrine attenuated Ang II-induced phosphorylation of MAPK in RTE cells (Fig. 2 ) and AA at low (1.5-3 M) concentrations mimicked the effect of Ang II on MAPK with a striking parallel in time course (Fig. 3) . Additional studies from this laboratory have documented that this PLA 2 -mediated signaling is linked to the relatively low affinity type 2 (AT 2 ) Ang II receptor (18, 22) that is pharmacologically distinct from the AT 2 receptor cloned previously (24, 25) . Moreover, this apical AT 2 receptor mediates Ang II-induced AA release and downstream events such as Shc͞Grb2͞Sos and p21 ras association (18, 22) . Thus, this represents an additional signaling model for AT 2 receptor subtypes and G proteincoupled receptors as well.
The question about specific isoform of PLA 2 , involved in the mechanism of Ang-II induced MAPK activation in RTE cells, is of great importance. The evidence obtained from our laboratory (19) and others (9) indicates a membraneassociated PLA 2 (mPLA 2 ) as the prime second messenger of Ang II in renal proximal tubule epithelium. This mPLA 2 is distinct from the cytosolic PLA 2 (cPLA 2 ), or the secretory PLA 2 (sPLA 2 ) by several criteria (19) . In RTE cells, a rapid activation of mPLA 2 (19) and AA release (18) is initiated within the first minutes of stimulation with Ang II and precedes the activation of MAPK, which in our experiments was significantly activated only after 5 min of incubation with Ang II (Fig. 3C) . In contrast, phosphorylation and activation of cPLA 2 induced by Ang II occurs later (after 15 min) and most likely is MAPK dependent as reported by others (19, 26) . The role of an alternate PLC͞diacylglycerol (DAG) lipasedependent source for AA in Ang II-induced MAPK activation also can be ruled out because (i) PLC is not activated by Ang II in RTE cells (7, 8) , and (ii) the specific inhibitor of DAG lipase RHC-80267 had no effect on the basal or Ang II-induced MAPK phosphorylation in RTE cells. Taken together, these data suggest the importance of a mPLA2 in the mechanism of Ang II-induced activation of MAPK in RTE cells. In support of this hypothesis are our observations that selective cPLA 2 inhibitor AACOCF 3 and selective sPLA 2 inhibitor manoalide did not attenuate MAPK phosphorylation induced by Ang II.
Our experiments suggest that the mechanism of MAPK activation by both Ang II and AA is PKC independent because a nonselective inhibitor of PKC staurosporine did not affect Ang II͞AA-induced but blocked PMA-induced MAPK phosphorylation (Fig. 4) . These results are in contrast to two previous reports using rat liver epithelial cells and vascular smooth muscle cells where PKC was documented to mediate AA-induced activation of MAPK (20, 21) . Using the current model, this laboratory has documented that both Ang II and AA stimulated the p21 ras -dependent pathway upstream of MAPK activation in RTE cells (22) , a PKC-independent signaling pathway (6). This pathway involves tyrosine phosphorylation of adaptor protein Shc, its association with Grb2͞ Sos complex followed by activation of p21 ras . In G proteincoupled receptor signaling, the adaptor protein Shc has been reported to be phosphorylated by Src-related tyrosine protein kinases (6) or by receptor tyrosine kinases (27) . The present studies provide linkage between the tyrosine kinase and this AT 2 receptor, placing mPLA 2 and AA upstream of Shc phosphorylation in the mechanism of MAPK activation by Ang II. More studies are in progress evaluating the mechanism whereby AA activates tyrosine kinase signaling.
In many cells, AA is metabolized by different enzymes into a variety of derivatives, which mediate its biological actions. In proximal tubule epithelium, cytochrome P450 enzymes represent a major Ang II-induced pathway of AA metabolism (28, 29) . Epoxy derivatives of AA (EETs) can mimic the effect of Ang II and AA on ion transport (7, 29) . In our experiments, the inhibitor of cytochrome P450 ketoconazole abolished MAPK phosphorylation induced by both Ang II and AA (Fig.  5) . Moreover, the relevant metabolites of AA in RTE cells 5,6-EET and 14,15-EET activated MAPK (Fig. 6 ). These data strongly suggest that cytochrome P450-dependent epoxy derivatives of AA may mediate the effect of Ang II and AA on MAPK phosphorylation. Of interest is the fact that the inhibitor of lipoxygenase nordihydroguaiaretic acid (NDGA) also abolished AA-induced MAPK phosphorylation. Some lipoxygenase products of AA (12-HETE, 15-HETE, leukotriene B 4 ) have been reported to activate MAPK in other cell types (11, 20, 23) . However, direct addition of these products to RTE cells had no effect on MAPK phosphorylation (data not shown). Moreover, because NDGA failed to inhibit Ang II-induced phosphorylation of MAPK (Fig. 5) , the involvement of lipoxygenase in the mechanism of MAPK activation by Ang II seems to be unlikely.
In conclusion, this study documents the essential role of a mPLA 2 , AA, and its cytochrome P450-dependent epoxy derivatives in PKC-independent phosphorylation of MAPK induced by Ang II. This represents an alternative mechanism of MAPK activation and may provide a linkage between this Ang II AT 2 receptor and the p21 ras -dependent pathway of activation of the MAPK cascade.
